Tag: AstraZeneca
-
Truqap Becomes the First Targeted Therapy for PTEN‑Deficient Metastatic Prostate Cancer
Prostate cancer remains one of the most common cancers affecting men worldwide, and while many cases respond well to early treatment, advanced forms of the disease can be far more difficult to manage. A major challenge has been finding effective therapies for aggressive subtypes that grow and spread quickly. One of these subtypes involves tumors…
-
Datroway Receives FDA Approval for Advanced Triple‑Negative Breast Cancer: What This Breakthrough Means for Patients
Triple‑negative breast cancer, often shortened to TNBC, has long been one of the most challenging forms of breast cancer to treat. Unlike other breast cancer types, TNBC does not have the three common receptors that many modern treatments target. This means patients have historically had fewer options, and many have had to rely on chemotherapy…
-
FDA Approves Fasenra as an Under the Skin Shot to Help Reduce Flares in Hypereosinophilic Syndrome
When the FDA approves a new treatment for a rare and difficult condition, it often marks a turning point for patients who have spent years dealing with unpredictable symptoms. That is exactly what happened with the approval of Fasenra, a medication given as an under the skin shot that has now been cleared to help…